Study 1: Current Phase 3 Obesity Study
Santos Research Center invites individuals to participate in a pivotal Phase 3 clinical trial focused on innovative treatment methods for obesity.
This trial is part of a comprehensive research initiative to develop more effective strategies for weight management and overall health improvement.
Study-related phone and in-clinic visits with Physician at no cost
Details
- Start Date: March 2024
- Phase: Phase 3
- Insurance: No insurance is needed
- Benefits: Medication for weight loss and compensation up to $2,000
Eligibility
- Male or female, age >=18 years
- BMI >=27 kg/m2
- Medical History of Heart Failure, Myocardial Infarction, or chronic kidney disease (CKD)
Excluding
- Previous treatment with glucagon-like peptide-1 receptor (GLP-1R) agonists 3 months before the 1st visit (Semaglutide)
- Type 1 Diabetes Mellitus
- History of either chronic or acute pancreatitis